These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3880047)

  • 1. Electron microscopic studies on tissue distribution of lipid microspheres used as drug delivery carriers.
    Shoji Y; Mizushima Y; Yanagawa A; Yonaha T
    Drugs Exp Clin Res; 1985; 11(9):601-9. PubMed ID: 3880047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A; Bergeron MG
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of iron removal from the reticuloendothelial system by liposome encapsulation of N,N'-bis[2-hydroxybenzyl]-ethylenediamine-N,N'-diacetic acid (HBED). Comparison with desferrioxamine.
    Lau EH; Cerny EA; Wright BJ; Rahman YE
    J Lab Clin Med; 1983 May; 101(5):806-16. PubMed ID: 6403640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
    Nakase H; Okazaki K; Tabata Y; Chiba T
    J Gastroenterol; 2003 Mar; 38 Suppl 15():59-62. PubMed ID: 12698874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stavudine-loaded mannosylated liposomes: in-vitro anti-HIV-I activity, tissue distribution and pharmacokinetics.
    Garg M; Asthana A; Agashe HB; Agrawal GP; Jain NK
    J Pharm Pharmacol; 2006 May; 58(5):605-16. PubMed ID: 16640829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomes designed to avoid the reticuloendothelial system.
    Papahadjopoulos D; Gabizon A
    Prog Clin Biol Res; 1990; 343():85-93. PubMed ID: 2198586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo.
    Hatakeyama H; Akita H; Maruyama K; Suhara T; Harashima H
    Int J Pharm; 2004 Aug; 281(1-2):25-33. PubMed ID: 15288340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies.
    Harrington KJ; Rowlinson-Busza G; Syrigos KN; Uster PS; Abra RM; Stewart JS
    Br J Cancer; 2000 Jul; 83(2):232-8. PubMed ID: 10901376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution and uptake of liposomes in vivo.
    Kamps JA; Scherphof GL
    Methods Enzymol; 2004; 387():257-66. PubMed ID: 15172169
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
    Li X; Ding L; Xu Y; Wang Y; Ping Q
    Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-efficacy site-directed drug delivery system using sialyl-Lewis X conjugated liposome.
    Hashida N; Ohguro N; Yamazaki N; Arakawa Y; Oiki E; Mashimo H; Kurokawa N; Tano Y
    Exp Eye Res; 2008 Jan; 86(1):138-49. PubMed ID: 18036523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-circulating liposomes.
    Oku N; Namba Y
    Crit Rev Ther Drug Carrier Syst; 1994; 11(4):231-70. PubMed ID: 7664348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of a drug delivery system to a steroidal ophthalmic preparation with lipid microspheres.
    Yanagawa A; Mizushima Y; Komatsu A; Horiuchi M; Shirasawa E; Igarashi R
    J Microencapsul; 1987; 4(4):329-31. PubMed ID: 3504514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced anti-inflammation of inhaled dexamethasone palmitate using mannosylated liposomes in an endotoxin-induced lung inflammation model.
    Wijagkanalan W; Higuchi Y; Kawakami S; Teshima M; Sasaki H; Hashida M
    Mol Pharmacol; 2008 Nov; 74(5):1183-92. PubMed ID: 18669445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ofloxacin targeting to lungs by way of microspheres.
    Harsha S; R C; Rani S
    Int J Pharm; 2009 Oct; 380(1-2):127-32. PubMed ID: 19646516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific binding of TES-23 antibody to tumour vascular endothelium in mice, rats and human cancer tissue: a novel drug carrier for cancer targeting therapy.
    Tsunoda S; Ohizumi I; Matsui J; Koizumi K; Wakai Y; Makimoto H; Tsutsumi Y; Utoguchi N; Taniguchi K; Saito H; Harada N; Ohsugi Y; Mayumi T
    Br J Cancer; 1999 Dec; 81(7):1155-61. PubMed ID: 10584876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation, preparation and evaluation of flunarizine-loaded lipid microspheres.
    Wang YJ; Wang J; Zhang HY; He HB; Tang X
    J Pharm Pharmacol; 2007 Mar; 59(3):351-7. PubMed ID: 17331337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nanometer lipid emulsion, lipid nano-sphere (LNS), as a parenteral drug carrier for passive drug targeting.
    Seki J; Sonoke S; Saheki A; Fukui H; Sasaki H; Mayumi T
    Int J Pharm; 2004 Apr; 273(1-2):75-83. PubMed ID: 15010132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes.
    Dams ET; Laverman P; Oyen WJ; Storm G; Scherphof GL; van Der Meer JW; Corstens FH; Boerman OC
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1071-9. PubMed ID: 10688625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel family of L-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity.
    Metselaar JM; Bruin P; de Boer LW; de Vringer T; Snel C; Oussoren C; Wauben MH; Crommelin DJ; Storm G; Hennink WE
    Bioconjug Chem; 2003; 14(6):1156-64. PubMed ID: 14624629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.